2021 SPRING NEWS

Feds Adopt National Strategy for Vector-Borne Diseases Group envisions a nation where vector-borne diseases no longer threaten human health and well-being.

By Lonnie Marcum

T he Kay Hagan Tick Act, passed in 2019, called for the US Department of Health and Human Services (HHS) to develop a national strategy to address issues related to vector-borne diseases. The idea was for HHS to co-ordinate with other federal agencies and departments, including the EPA, the Department of Defense, and others, to get everybody working towards the same goals.

The Kay Hagan Tick Act adopts a national strategy for Lyme disease

In an encouraging development, CDC representative Ben Beard made an important announcement about it at the Tick-Borne Disease Working Group (TBDWG) meeting on September 22, 2020. It’s called “A National Public Health Framework for the Prevention and Control of Vector-Borne Diseases in Humans.” The cover of the new plan represents ticks, mosquitoes, and fleas—all vectors that pose public health risks.

The following is taken from the CDC website.

The Framework

The National Strategy shall include objectives, activities, performance metrics, as well as a coordination and monitoring plan.

The Vision

A nation where vector-borne diseases no longer threaten human health and well-being

The Purpose

Protect people from illness, suffering, and death due to vector- borne diseases.

The Goals

  1. Better understand when, where, and how people are exposed to and get sick or die from vector-borne diseases
  2. Develop, evaluate, and improve tools and guidance for the diagnosis and detection of vector-borne diseases
  3. Develop, evaluate, and improve tools and guidance for the prevention and control of vector-borne diseases
  4. Develop and assess drugs and treatment strategies for vector-borne diseases
  5. Disseminate and support the implementation of effective public health and vector control products, tools, and programs to prevent, detect, diagnose, and respond to vector-borne disease threats

Join or login below to continue reading.

You must be a LymeDisease.org member to access this content.

If you are already a member, log in below. Otherwise, become a member today to access the full content of this article and the full library of Lyme Times articles.
* Physician Directory Memberships do not have access to the Lyme Times.
Become A Member
Login
patient-doctors-missed-lyme-disease-img1

Related Articles
ILADS Guidelines
ILADS Guidelines Authors Defend Their Conclusion that Scientific Evidence from Lyme Clinical Trials is “Weak” IDSA overstates the quality of the evidence it uses to deny care to chronically ill patients who fail standard treatment.
Interview Dr. Kinderlehrer about disulfiram for Lyme disease
A patient interviews Dr. Kinderlehrer about disulfiram for Lyme disease Many Lyme patients report feeling greatly improved after disulfiram therapy.
MyLymeData: A Patient-Centered Presentation
MyLymeData: A Patient-Centered Presentation to the Tick-Borne Disease Working Group Lorraine Johnson, CEO of LymeDisease.org, shares data from the MyLymeData research project as well as her own personal experiences with Lyme disease.
A Lyme Rash Doesn't Always Look Like a Bulls-eye Target
A Lyme Rash Doesn’t Always Look Like a Bulls-eye Target Misconceptions about rashes can lead to people being told they don't have Lyme disease when they actually do
Lyme disease a biological weapons experiment
Was Lyme disease a biological weapons experiment? Kris Newby's new book, Bitten, explores the possibility of biological warfare and Lyme disease.
Advocates Zoom with Congress for More Lyme Funding
Advocates Zoom with Congress to Push for More Lyme Funding 200 people helped educate Congressional representatives via “Virtual Lyme Fly-in.”